FG001 again demonstrates strong data in guiding glioblastoma surgery – accepted for presentation at the World Molecular Imaging Congress 2019

FluoGuide A/S ("FluoGuide") today announces that new data confirms FG001’s potential in guiding surgical removal of glioblastoma. The data will be presented at the World Molecular Imaging Congress 2019 (WMIC) in Montreal, on September 4-7

The release as fetched from its publisher. fluoguide.com ↗